纳米生物技术在个性化医疗发展中的作用。 - Suppr

Suppr

超能文献

The role of nanobiotechnology in the development of personalized medicine.

作者信息

Jain K K

机构信息

Jain PharmaBiotech, Basel, Switzerland. jain @ pharmabiotech.ch

出版信息

Med Princ Pract. 2011;20(1):1-3. doi: 10.1159/000319928. Epub 2010 Dec 13.

DOI:10.1159/000319928

PMID:21160206

Abstract

摘要

相似文献

The role of nanobiotechnology in the development of personalized medicine.

Med Princ Pract. 2011;20(1):1-3. doi: 10.1159/000319928. Epub 2010 Dec 13.

Nanobiotechnology and personalized medicine.

Prog Mol Biol Transl Sci. 2011;104:325-54. doi: 10.1016/B978-0-12-416020-0.00008-5.

The role of nanobiotechnology in drug discovery.

Drug Discov Today. 2005 Nov 1;10(21):1435-42. doi: 10.1016/S1359-6446(05)03573-7.

'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems.

Int J Pharm. 2011 Aug 30;415(1-2):5-8. doi: 10.1016/j.ijpharm.2011.02.010. Epub 2011 Feb 12.

Role of nanobiotechnology in the personalized management of glioblastoma multiforme.

Nanomedicine (Lond). 2011 Apr;6(3):411-4. doi: 10.2217/nnm.11.12.

Role of nanobiotechnology in the development of personalized medicine.

Nanomedicine (Lond). 2009 Apr;4(3):249-52. doi: 10.2217/nnm.09.12.

Progress towards personalized medicine.

Drug Discov Today. 2010 Feb;15(3-4):115-20. doi: 10.1016/j.drudis.2009.11.001. Epub 2009 Nov 13.

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.

Crit Rev Clin Lab Sci. 2010 May-Jun;47(3):125-38. doi: 10.3109/10408363.2010.503558. Epub 2010 Sep 21.

A challenging drug development process in the era of personalized medicine.

Drug Discov Today. 2011 Oct;16(19-20):891-7. doi: 10.1016/j.drudis.2011.09.010. Epub 2011 Sep 18.

Legal developments and practical implications of gene patenting on targeted drug discovery and development.

Clin Pharmacol Ther. 2010 Jun;87(6):633-5. doi: 10.1038/clpt.2010.47.

引用本文的文献

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy.

Materials (Basel). 2019 May 15;12(10):1588. doi: 10.3390/ma12101588.

Personalized Management of Cardiovascular Disorders.

Med Princ Pract. 2017;26(5):399-414. doi: 10.1159/000481403. Epub 2017 Sep 11.

Emerging metrology for high-throughput nanomaterial genotoxicology.

Mutagenesis. 2017 Jan;32(1):215-232. doi: 10.1093/mutage/gew037. Epub 2016 Aug 26.

Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.

Med Princ Pract. 2016;25(5):399-407. doi: 10.1159/000447670. Epub 2016 Jun 17.

Cancer nanomedicines: closing the translational gap.

Lancet. 2014 Dec 20;384(9961):2175-6. doi: 10.1016/S0140-6736(14)61457-4. Epub 2014 Dec 19.

Superparamagnetic iron oxide-enhanced magnetic resonance imaging in a case of spleen hamartoma.

Med Princ Pract. 2013;22(3):301-3. doi: 10.1159/000343577. Epub 2012 Oct 27.

Synthetic biology and personalized medicine.

Med Princ Pract. 2013;22(3):209-19. doi: 10.1159/000341794. Epub 2012 Aug 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The role of nanobiotechnology in the development of personalized medicine.

Med Princ Pract. 2011;20(1):1-3. doi: 10.1159/000319928. Epub 2010 Dec 13.

Nanobiotechnology and personalized medicine.

Prog Mol Biol Transl Sci. 2011;104:325-54. doi: 10.1016/B978-0-12-416020-0.00008-5.

The role of nanobiotechnology in drug discovery.

Drug Discov Today. 2005 Nov 1;10(21):1435-42. doi: 10.1016/S1359-6446(05)03573-7.

'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems.

Int J Pharm. 2011 Aug 30;415(1-2):5-8. doi: 10.1016/j.ijpharm.2011.02.010. Epub 2011 Feb 12.

Role of nanobiotechnology in the personalized management of glioblastoma multiforme.

Nanomedicine (Lond). 2011 Apr;6(3):411-4. doi: 10.2217/nnm.11.12.

Role of nanobiotechnology in the development of personalized medicine.

Nanomedicine (Lond). 2009 Apr;4(3):249-52. doi: 10.2217/nnm.09.12.

Progress towards personalized medicine.

Drug Discov Today. 2010 Feb;15(3-4):115-20. doi: 10.1016/j.drudis.2009.11.001. Epub 2009 Nov 13.

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.

Crit Rev Clin Lab Sci. 2010 May-Jun;47(3):125-38. doi: 10.3109/10408363.2010.503558. Epub 2010 Sep 21.

A challenging drug development process in the era of personalized medicine.

Drug Discov Today. 2011 Oct;16(19-20):891-7. doi: 10.1016/j.drudis.2011.09.010. Epub 2011 Sep 18.

Legal developments and practical implications of gene patenting on targeted drug discovery and development.

Clin Pharmacol Ther. 2010 Jun;87(6):633-5. doi: 10.1038/clpt.2010.47.

引用本文的文献

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy.

Materials (Basel). 2019 May 15;12(10):1588. doi: 10.3390/ma12101588.

Personalized Management of Cardiovascular Disorders.

Med Princ Pract. 2017;26(5):399-414. doi: 10.1159/000481403. Epub 2017 Sep 11.

Emerging metrology for high-throughput nanomaterial genotoxicology.

Mutagenesis. 2017 Jan;32(1):215-232. doi: 10.1093/mutage/gew037. Epub 2016 Aug 26.

Med Princ Pract. 2016;25(5):399-407. doi: 10.1159/000447670. Epub 2016 Jun 17.

Cancer nanomedicines: closing the translational gap.

Lancet. 2014 Dec 20;384(9961):2175-6. doi: 10.1016/S0140-6736(14)61457-4. Epub 2014 Dec 19.

Superparamagnetic iron oxide-enhanced magnetic resonance imaging in a case of spleen hamartoma.

Med Princ Pract. 2013;22(3):301-3. doi: 10.1159/000343577. Epub 2012 Oct 27.

Synthetic biology and personalized medicine.

Med Princ Pract. 2013;22(3):209-19. doi: 10.1159/000341794. Epub 2012 Aug 16.